Similar articles

Abstract: Based on recent molecular data, it has been suggested that Sporothrix globosa is the main causal agent of sporotrichosis in China. The objective of this study was to compare the morphology, growth characteristics, patterns of carbon source usage, and susceptibility to antifungal agents among Sporothrix strains. A total of 15 clinical strains confirmed to be S. globosa, from three different regions of China, and 11 ex-type strains from the CBS-KNAW biodiversity center were obtained. The elongated conidia of S. pallida, S. variecibatus, S. schenckii, and S. schenckii luriei were clearly different from the subglobose and globose conidia of S. globosa strains. S. schenckii is able to assimilate sucrose, raffinose, and ribitol. Susceptibility profiles of these Sporothrix species were evaluated by measuring minimum inhibitory concentrations (MICs). Fluconazole, itraconazole, terbinafine, and amphotericin B showed good activity against most S. globosa clinical isolates from China. Potassium iodide also showed a low MIC against S. pallida, while fluconazole showed a high MIC for S. mexicana, S. humicola, S. globosa, S. schenckii, and S. inflata; these strains might be considered tolerant. The species showed differences in susceptibility to antifungal drugs and should therefore be properly identified during diagnosis prior to designing therapeutic strategies.

申克孢子丝菌复合体在形态学和生理生化的研究

[1]de Lima Barros, M.B., de Oliveira Schubach, A., do Valle, A.C.F., et al., 2004. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin. Infect. Dis., 38(4):529-535.

[2]de Meyer, E.M., de Beer, Z.W., Summerbell, R.C., et al., 2008. Taxonomy and phylogeny of new wood- and soil-inhabiting Sporothrix species in the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia, 100(4):647-661.

[3]Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A., et al., 2002. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J. Clin. Microbiol., 40(10):3776-3781.

[4]Kohler, L.M., Monteiro, P.C., Hahn, R.C., et al., 2004. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine. J. Clin. Microbiol., 42(9):4319-4320.

[5]Liu, T.T., Zhang, K., Zhou, X., 2014. Molecular identification of Sporothrix clinical isolates in China. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 15(1):100-108.

[6]Marimon, R., Cano, J., Gené, J., et al., 2007. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J. Clin. Microbiol., 45(10):3198-3206.

[7]Marimon, R., Serena, C., Gené, J., et al., 2008. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob. Agents Chemother., 52(2):732-734.

[8]Oliveira, D.C., Lopes, P.G., Spader, T.B., et al., 2011. Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J. Clin. Microbiol., 49(8):3047-3049.

[9]O'Reilly, L.C., Altman, S.A., 2006. Macrorestriction analysis of clinical and environmental isolates of Sporothrix schenckii. J. Clin. Microbiol., 44(7):2547-2552.

[10]Rodrigues, A.M., de Hoog, G.S., de Cássia Pires, D., et al., 2014. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect. Dis., 14(1):219.

[11]Silva-Vergara, M.L., de Camargo, Z.P., Silva, P.F., et al., 2012. Disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient. Am. J. Trop. Med. Hyg., 86(3):477-480.

[12]Tan, J.W., Liu, W., Wan, Z., et al., 2013. Reclassification of 33 clinical strains of Sporothrix from northern China based on phenotypic and molecular characters. Mycosystema, 32(2):161-167 (in Chinese).

[13]Trilles, L., Fernández-Torres, B., dos Santos Lazéra, M., et al., 2005. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob. Agents Chemother., 49(9):3952-3954.

[14]Yu, X., Wan, Z., Zhang, Z., et al., 2013. Phenotypic and molecular identification of Sporothrix isolates of clinical origin in Northeast China. Mycopathologia, 176(1-2):67-74.

[15]Zhang, J.D., Lin, J.P., 2008. Clinical analysis of 316 cases of cutaneous sporotrichosis. Chin. J. Mycol., 3(4):207-210 (in Chinese).

[16]Zhou, X., Rodrigues, A.M., Feng, P., et al., 2014. Global ITS diversity in the Sporothrix schenckii complex. Fungal Divers., 66(1):153-165.